Fulminant hepatitis associated with hepatitis B virus e antigen–negative infection: Importance of host factors
暂无分享,去创建一个
[1] H C Thomas,et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. , 1995, The New England journal of medicine.
[2] H. Thomas,et al. Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants , 1995, Journal of viral hepatitis.
[3] K. Hasegawa,et al. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis , 1994, Journal of virology.
[4] T. Shikata,et al. Completely or nearly identical hepatitis B virus strains replicate between patients with acute or fulminant hepatitis B and their respective infectious sources , 1994, Journal of medical virology.
[5] A. Horsch,et al. Clinical significance of quantitative anti-HBc IgM assay in acute and chronic HBV infection. , 1993, Hepato-gastroenterology.
[6] M. Bunce,et al. Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence-specific primers (PCR-SSP). , 1993, Human immunology.
[7] R. Purcell,et al. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. , 1993, Virology.
[8] A. Vitiello,et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein , 1993, Journal of virology.
[9] O. Yokosuka,et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. , 1993, The Journal of clinical investigation.
[10] S. Mishiro,et al. Fulminant hepatitis related to transmission of hepatitis B variants with precore mutations between spouses , 1992, Hepatology.
[11] D. Kelly,et al. Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. , 1992, BMJ.
[12] F. Chisari,et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[13] F. Chisari,et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen , 1991, The Journal of experimental medicine.
[14] H. Thomas,et al. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis , 1991, Hepatology.
[15] O. Yokosuka,et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. , 1991, The New England journal of medicine.
[16] J. Wands,et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.
[17] O. Yokosuka,et al. Amino acid residues of core region of hepatitis B virus. Asymptomatic carriers versus patients with liver disease , 1991, Journal of gastroenterology and hepatology.
[18] K. Takase,et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. , 1991, Gastroenterology.
[19] F. Tsuda,et al. Posttransfusion Fulminant Hepatitis B Associated with Precore‐Defective HBV Mutants , 1991, Vox sanguinis.
[20] H. Thomas,et al. MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1989, The Lancet.
[21] M. Alter,et al. A common-source outbreak of fulminant hepatitis B in a hospital. , 1989, Annals of internal medicine.
[22] A. Alberti,et al. Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. , 1987, Clinical and experimental immunology.
[23] Roger Williams,et al. FULMINANT HEPATITIS B IN SUCCESSIVE FEMALE SEXUAL PARTNERS OF TWO ANTI-HBe-POSITIVE MALES , 1986, The Lancet.
[24] H. Thomas,et al. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection , 1986, Hepatology.
[25] D. Vergani,et al. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. , 1982, Journal of immunology.
[26] F. Galibert,et al. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli , 1979, Nature.
[27] J. Squire,et al. SECOND THOUGHTS ON THE WILLINK REPORT , 1960 .
[28] O. Yokosuka,et al. Precore mutations and core clustering mutations in chronic hepatitis B virus infection. , 1993, Gastroenterology.
[29] J. Sung,et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.
[30] Brunetto. Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis , 1989 .
[31] B. Schwartz. Letter: Ondine's curse. , 1976, Lancet.